CINECA IRIS Institutional Research Information System

TADDEI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.022
AS - Asia 17.984
EU - Europa 16.398
SA - Sud America 2.805
Continente sconosciuto - Info sul continente non disponibili 789
AF - Africa 619
OC - Oceania 54
Totale 81.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.759
SG - Singapore 5.467
IT - Italia 5.163
CN - Cina 5.079
HK - Hong Kong 3.219
FI - Finlandia 2.531
BR - Brasile 2.337
SE - Svezia 2.011
DE - Germania 1.555
VN - Vietnam 1.426
BG - Bulgaria 1.203
CA - Canada 928
GB - Regno Unito 865
TR - Turchia 819
FR - Francia 771
RU - Federazione Russa 611
UA - Ucraina 570
KR - Corea 436
IN - India 398
CH - Svizzera 235
JP - Giappone 230
CI - Costa d'Avorio 204
AR - Argentina 169
BD - Bangladesh 153
SM - San Marino 140
AT - Austria 137
MX - Messico 111
NL - Olanda 109
BE - Belgio 104
ID - Indonesia 103
IQ - Iraq 102
ZA - Sudafrica 94
PK - Pakistan 77
PL - Polonia 77
SN - Senegal 72
EC - Ecuador 71
ES - Italia 70
SA - Arabia Saudita 67
UZ - Uzbekistan 63
CO - Colombia 61
JM - Giamaica 61
VE - Venezuela 61
CR - Costa Rica 45
CZ - Repubblica Ceca 41
AU - Australia 40
MA - Marocco 40
BJ - Benin 36
PH - Filippine 32
PY - Paraguay 31
JO - Giordania 30
MY - Malesia 29
KE - Kenya 27
IE - Irlanda 26
OM - Oman 26
CL - Cile 25
TN - Tunisia 25
UY - Uruguay 25
EG - Egitto 24
NG - Nigeria 24
NP - Nepal 24
NI - Nicaragua 23
AE - Emirati Arabi Uniti 22
DZ - Algeria 21
KZ - Kazakistan 21
RO - Romania 21
IL - Israele 19
LT - Lituania 19
AZ - Azerbaigian 17
HR - Croazia 16
TT - Trinidad e Tobago 15
KG - Kirghizistan 14
GR - Grecia 13
PE - Perù 13
TH - Thailandia 13
AL - Albania 12
GT - Guatemala 12
HU - Ungheria 12
LB - Libano 12
PT - Portogallo 12
SV - El Salvador 12
IR - Iran 11
NZ - Nuova Zelanda 11
EU - Europa 10
LV - Lettonia 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
HN - Honduras 9
PS - Palestinian Territory 9
SY - Repubblica araba siriana 9
TW - Taiwan 9
BH - Bahrain 8
ET - Etiopia 8
NO - Norvegia 8
PA - Panama 8
AO - Angola 7
DK - Danimarca 7
GE - Georgia 7
LU - Lussemburgo 7
RS - Serbia 7
BB - Barbados 6
Totale 80.757
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.300
Ashburn 4.032
Ann Arbor 3.281
Hong Kong 3.161
Singapore 3.078
Fairfield 3.061
Houston 2.802
San Jose 2.337
Helsinki 2.031
Chandler 1.893
Santa Clara 1.747
Dallas 1.382
Sofia 1.198
Seattle 1.189
Serra 1.103
Shanghai 1.078
Cambridge 1.049
Wilmington 1.047
Beijing 1.045
Milan 970
New York 879
Council Bluffs 731
Jacksonville 719
Ottawa 685
Boardman 587
Hefei 538
Princeton 525
Los Angeles 517
Lawrence 486
Izmir 472
Medford 433
Lauterbourg 431
Seoul 422
Nanjing 404
Munich 363
Ho Chi Minh City 327
Des Moines 310
Istanbul 245
Hanoi 237
Buffalo 212
Rome 208
Lancaster 206
Abidjan 204
Dearborn 202
Tokyo 201
Florence 200
Pisa 200
Dong Ket 197
Frankfurt am Main 194
São Paulo 194
Redondo Beach 189
Nanchang 187
Bern 184
San Diego 166
London 138
The Dalles 137
Boulder 130
Columbus 130
Falls Church 115
Kunming 114
Paris 113
Jüchen 109
Vienna 106
Chicago 98
Ogden 89
Brussels 86
Redwood City 81
Shenyang 81
Belo Horizonte 78
Rio de Janeiro 75
Toronto 74
Changsha 70
Dakar 70
Turku 70
Phoenix 69
Norwalk 68
Orem 65
Atlanta 64
Pune 64
Hebei 62
Washington 62
Tianjin 61
Warsaw 61
Tashkent 56
San Francisco 54
Fuzhou 53
Jiaxing 52
Brooklyn 51
Naples 49
Denver 48
Bologna 45
Brasília 45
Jakarta 44
Baghdad 43
Montreal 43
Da Nang 42
Amsterdam 41
Detroit 41
Nuremberg 41
Kingston 39
Totale 57.366
Salva come PNG Salva come JPEG
Nome #
ANF IN PRIMARY ALDOSTERONISM - EFFECT OF DIETARY NA+ AND POSTURAL CHANGES AND RELATIONSHIP WITH ALDOSTERONE 2.048
Calcolo dell’Età Vascolare: un nuovo e concreto target terapeutico 1.771
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 514
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 506
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 478
Phosphodiesterase 5 inhibition in essential hypertension. 370
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 334
Habitual physical activity and arterial stiffness in normotensive and hypertensive subjects 296
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 282
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 278
Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method 277
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. 265
Potassium-rich and sodium-poor salt reduces blood pressure in hospitalized patients. 259
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes 259
INCREASED CENTRAL PRESSURE AUGMENTATION IS ASSOCIATED WITH REDUCED SLEEP DURATION IN INDIVIDUALS EXPOSED TO AIRCRAFT NOISE POLLUTION: THE SERA-CV STUDY 252
Correlation between Vascular Age and surrogate markers of atherosclerosis and vascular aging 248
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 244
Active and inactive renin in human forearm of hypertensive patients. 242
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 239
Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors 238
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH) 237
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 234
Cigarette Smoking and Hypertension 231
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 231
Cardiovascular parameter changes in patients with erectile dysfunction using Pde-5 inhibitors: A study with sildenatil and vardenatil 231
Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications 223
Renal changes induced by nitric oxide and prostaglandin synthesis reduction: effects of trandolapril and verapamil. 222
Endothelial Function and Renal Vasodilation, But not Arterial Stiffness, are Impaired in Lean, Normotensive Patients with Sleep-Apnea Syndrome 221
“Cardiovascular parameters changes in patients with erectile dysfunction using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 10 mg.” 220
Device-based therapies for resistant hypertension. 220
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 218
Obesity in the childhood: a link to adult hypertension 217
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: A pilot study 213
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 212
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 212
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 211
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 210
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 210
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 209
Sporadic or familial head neck paragangliomas enrolled in a single center: Clinical presentation and genotype/phenotype correlations 209
Angiotensin-converting enzyme inhibitors in hypertension: a review. Int 206
Circulating mitochondrial DNA signature in cardiometabolic patients 205
Systemic Inflammation after Third Molar Removal: A Case-Control Study 205
Multiparametric evaluation of vascular function in lean, normotensive patients with obstructive sleep apnoea 204
Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients 204
Vascular renin-angiotensin system and neurotransmission in hypertensive persons. 203
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 201
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 201
Adipocytokine levels mark endothelial function in normotensive individuals 200
Effects of Low-Carbohydrate versus Mediterranean Diets on Weight Loss, Glucose Metabolism, Insulin Kinetics and β-Cell Function in Morbidly Obese Individuals 200
Lack of evidence for Na/K ATPase inhibitor as a cause of low renin human hypertension. 199
Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2. 199
Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension. 198
Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story? 198
Cholecalciferol treatment downregulates renin-angiotensin systemand improves endothelial function in essential hypertensive patients with hypovitaminosid D 198
Narrare la malattia per costruire la salute. Una prospettiva multidisciplinare 198
Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses. Hypertension. 197
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection 197
Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: the European Prospective Investigation into Cancer and Nutrition-Florence cohort 197
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 197
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 197
Birth weight and arterial hypertension 197
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 196
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 195
The effects of diuretic and beta-blocker treatment on cardiac and vascular structural changes in untreated essential hypertensive patients. 194
Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis 194
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 194
Pathogenetic factors in hypertension. Endothelial factors. 193
Functional and structural alterations of large arteries: methodological issues. 193
Third molar surgical removal: a possible model of human systemic inflammation? A preliminary investigation 192
Renal Resistive Index Predicts Post–Bariatric Surgery Renal Outcome in Nondiabetic Individuals with Severe Obesity 192
Cardiovascular parameter changes in patients with erectile dysfunction using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 20 mg 191
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 190
Vascular tissue renin-angiotensin system in hypertensive humans. 189
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients 189
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus 188
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 188
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 187
Endothelium-dependent vasodilation in hypertensive patients 186
Adenosine causes angiotensin II release in human forearm arterioles. 186
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 186
Donepezil improves vascular function in a mouse model of Alzheimer's disease 186
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 185
Calcium entry blockade and selective alpha-adrenergic stimulation in animals and humans 184
At the beginning of stiffening: endothelial dysfunction meets "pulsology" 184
Hypertension in special populations: athletes. 184
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 184
A renin-secreting tumor 184
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 184
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 184
The relationship between naevus count, memory function and telomere length in the Twins UK cohort 184
Spectrum of depressive disorders and cardiovascular diseases: clinical and psychobiological evidences of a bidirectional relationship 184
Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients. 183
Microalbuminuria and renal haemodynamics in essential hypertension. 183
Coronary macro- and micricirculatory response to to adenosine and nitrates in patients with syndrome x: a study by transesophageal coronary doppler 183
Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. 183
Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. 183
Hypertension causes premature aging of endothelial function in humans 183
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 182
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 181
Totale 25.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.994 0 0 106 380 1.029 726 162 324 259 204 321 1.483
2022/20236.008 777 671 360 518 610 819 84 463 1.055 79 430 142
2023/20244.874 543 491 568 363 692 832 187 188 141 111 206 552
2024/202515.802 169 637 272 853 1.339 1.699 1.386 1.003 1.639 2.152 1.777 2.876
2025/202617.558 968 1.992 1.872 1.441 1.609 1.533 2.329 736 2.741 1.423 550 364
2026/20274.802 635 1.784 2.383 0 0 0 0 0 0 0 0 0
Totale 81.671